---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-040184"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T04:51:53.572272+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences amends asset purchase deal; price cut to $2.25M, deadline to June 30

## Summary
- Exercise price under Asset Purchase Agreement reduced from $5.16M to $2.25M.
- Termination date extended from March 31, 2025 to June 30, 2025.
- Amendment dated April 25, 2025, between ReShape and Ninjour Health International Limited.
- Original Asset Purchase Agreement was entered into on July 8, 2024.

## SEC filing metadata
- accession: 0001104659-25-040184
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925040184/0001104659-25-040184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925040184/tm2513212d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-040184
- JSON: https://secwatch.observer/filing/0001104659-25-040184.json
- Plain text: https://secwatch.observer/filing/0001104659-25-040184.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.